Probiotics for GI Health in 2012: Issues and Updates
After participating in this educational activity, participants should be better able to:
|1.||Differentiate among probiotics and their utility for specific GI issues|
|2.||Counsel patients in clinical practice regarding probiotics utilizing current guidelines and evidence-based data|
Microbiota, often referred to as microflora, in the human gastrointestinal (GI) tract comprise a complex community of microorganisms that contribute to a variety of local and systemic functions vital to development and well-being. There is substantial interest in using probiotics to target the GI microbiota to promote health, and probiotic use has grown rapidly over the last decade. In addition, the number of clinical trials assessing probiotics in humans also has increased substantially in recent years. To assist patients in making informed decisions regarding the use of probiotics for GI health, clinicians should be aware of the similarities and differences among the growing number of probiotics available, and be knowledgeable regarding the current data and guidelines supporting their use. This review on the efficacy of probiotics in GI disorders is designed to provide guidance to primary care clinicians who wish to provide evidence-based probiotic information to their patients. The goal of this educational activity is to improve patient outcomes through the evidence-based use of probiotics for GI health.
This activity has expired and is no longer available for CME; however, we hope you still enjoy the education.
Published on November 13, 2012